In HCC cells, HBV protein HBx upregulates translation regulatory lncRNA1 (TRERNA1), which upregulates NRAS and activates the RAF/MEK/ERK pathway by sponging miR-22-3p, thereby conferring sorafenib resistance [137]. The gene discussed is MAP2K7; the disease is hepatocellular carcinoma.